With only 15 months left for banks to meet the deadline for the new share capital benchmarks, the Central Bank has warned ...

Globus Medical, Inc.’s GMED growth in the third quarter can be attributed to the robust prospect in the musculoskeletal space ...

Globus reported $626 million in sales and $48 million in operating profit for the quarter ending September 30, 2024, which ...

Sanctuary Advisors LLC raised its holdings in Globus Medical, Inc. (NYSE:GMED – Free Report) by 33.9% in the 3rd quarter, ...

Piper Sandler analyst Matthew O’Brien maintained a Buy rating on Globus Medical (GMED – Research Report) today and set a price target of ...

Stay well-informed and make prudent decisions using our Ratings Table. Globus Medical Inc is a medical device company that ...

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Globus Medical (GMED) primarily specializes in offering a diverse range of devices for spinal surgeries. The company also provides products for knee and hip procedures, along with robotic and imaging ...

BTIG analyst Ryan Zimmerman maintained a Buy rating on Globus Medical (GMED – Research Report) today and set a price target of $91.00. The ...

Equities researchers at Zacks Research increased their Q3 2025 EPS estimates for Globus Medical in a research report issued ...

Stocks to watch on Monday, December 16, 2024: Indian equities are expected to have a sluggish start on Monday, according to ...